67 related articles for article (PubMed ID: 19890231)
1. Factors associated with concomitant psychotropic drug use in the treatment of major depression: a STAR*D Report.
Shelton RC; Hollon SD; Wisniewski SR; Alpert JE; Balasubramani GK; Friedman ES; Rush AJ; Trivedi MH; Preskorn SH
CNS Spectr; 2009 Sep; 14(9):487-98. PubMed ID: 19890231
[TBL] [Abstract][Full Text] [Related]
2. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR
Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774
[TBL] [Abstract][Full Text] [Related]
3. Quality of Life and Functioning in Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder After Treatment With Citalopram Monotherapy.
Steiner AJ; Boulos N; Mirocha J; Wright SM; Collison KL; IsHak WW
Clin Neuropharmacol; 2017; 40(1):16-23. PubMed ID: 27764051
[TBL] [Abstract][Full Text] [Related]
4. What predicts attrition in second step medication treatments for depression?: a STAR*D Report.
Warden D; Rush AJ; Wisniewski SR; Lesser IM; Kornstein SG; Balasubramani GK; Thase ME; Preskorn SH; Nierenberg AA; Young EA; Shores-Wilson K; Trivedi MH
Int J Neuropsychopharmacol; 2009 May; 12(4):459-73. PubMed ID: 18611293
[TBL] [Abstract][Full Text] [Related]
5. Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
Rush AJ; Wisniewski SR; Warden D; Luther JF; Davis LL; Fava M; Nierenberg AA; Trivedi MH
Arch Gen Psychiatry; 2008 Aug; 65(8):870-80. PubMed ID: 18678792
[TBL] [Abstract][Full Text] [Related]
6. Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.
Sung SC; Wisniewski SR; Balasubramani GK; Zisook S; Kurian B; Warden D; Trivedi MH; Rush AJ;
Psychol Med; 2013 May; 43(5):945-60. PubMed ID: 23228340
[TBL] [Abstract][Full Text] [Related]
7. Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report.
Rush AJ; Wisniewski SR; Zisook S; Fava M; Sung SC; Haley CL; Chan HN; Gilmer WS; Warden D; Nierenberg AA; Balasubramani GK; Gaynes BN; Trivedi MH; Hollon SD
Psychol Med; 2012 Jun; 42(6):1131-49. PubMed ID: 22008447
[TBL] [Abstract][Full Text] [Related]
8. Depression outcomes of Spanish- and english-speaking Hispanic outpatients in STAR*D.
Lesser I; Rosales A; Zisook S; Gonzalez C; Flores D; Trivedi M; Sciolla A; Luther J; Wisniewski S; Alpert J; Cook I; Rush AJ; Epstein M
Psychiatr Serv; 2008 Nov; 59(11):1273-84. PubMed ID: 18971403
[TBL] [Abstract][Full Text] [Related]
9. Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes.
Davis LL; Wisniewski SR; Howland RH; Trivedi MH; Husain MM; Fava M; McGrath PJ; Balasubramani GK; Warden D; Rush AJ
Drug Alcohol Depend; 2010 Mar; 107(2-3):161-70. PubMed ID: 19945804
[TBL] [Abstract][Full Text] [Related]
10. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report.
Leuchter AF; Husain MM; Cook IA; Trivedi MH; Wisniewski SR; Gilmer WS; Luther JF; Fava M; Rush AJ
Psychol Med; 2010 Feb; 40(2):239-51. PubMed ID: 19493369
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in response to citalopram: a STAR*D report.
Young EA; Kornstein SG; Marcus SM; Harvey AT; Warden D; Wisniewski SR; Balasubramani GK; Fava M; Trivedi MH; John Rush A
J Psychiatr Res; 2009 Feb; 43(5):503-11. PubMed ID: 18752809
[TBL] [Abstract][Full Text] [Related]
12. Ethnicity/race and outcome in the treatment of depression: results from STAR*D.
Lesser IM; Castro DB; Gaynes BN; Gonzalez J; Rush AJ; Alpert JE; Trivedi M; Luther JF; Wisniewski SR
Med Care; 2007 Nov; 45(11):1043-51. PubMed ID: 18049344
[TBL] [Abstract][Full Text] [Related]
13. Income and attrition in the treatment of depression: a STAR*D report.
Warden D; Rush AJ; Wisniewski SR; Lesser IM; Thase ME; Balasubramani GK; Shores-Wilson K; Nierenberg AA; Trivedi MH
Depress Anxiety; 2009; 26(7):622-33. PubMed ID: 19582825
[TBL] [Abstract][Full Text] [Related]
14. Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder.
Saghafi R; Brown C; Butters MA; Cyranowski J; Dew MA; Frank E; Gildengers A; Karp JF; Lenze EJ; Lotrich F; Martire L; Mazumdar S; Miller MD; Mulsant BH; Weber E; Whyte E; Morse J; Stack J; Houck PR; Bensasi S; Reynolds CF
Int J Geriatr Psychiatry; 2007 Nov; 22(11):1141-6. PubMed ID: 17486678
[TBL] [Abstract][Full Text] [Related]
15. Riluzole combination therapy for moderate-to-severe major depressive disorder: A randomized, double-blind, placebo-controlled trial.
Salardini E; Zeinoddini A; Mohammadinejad P; Khodaie-Ardakani MR; Zahraei N; Zeinoddini A; Akhondzadeh S
J Psychiatr Res; 2016 Apr; 75():24-30. PubMed ID: 26800392
[TBL] [Abstract][Full Text] [Related]
16. Quality of Life, Functioning, and Depressive Symptom Severity in Older Adults With Major Depressive Disorder Treated With Citalopram in the STAR*D Study.
Steiner AJ; Recacho J; Vanle B; Dang J; Wright SM; Miller JS; Kauzor K; Reid M; Bashmi LE; Mirocha J; Danovitch I; IsHak WW
J Clin Psychiatry; 2017 Jul; 78(7):897-903. PubMed ID: 28858443
[TBL] [Abstract][Full Text] [Related]
17. Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.
Gaynes BN; Dusetzina SB; Ellis AR; Hansen RA; Farley JF; Miller WC; Stürmer T
J Clin Psychopharmacol; 2012 Feb; 32(1):114-9. PubMed ID: 22198447
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study.
Brown ES; Vigil L; Khan DA; Liggin JD; Carmody TJ; Rush AJ
Biol Psychiatry; 2005 Dec; 58(11):865-70. PubMed ID: 15993860
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].
Norton J; de Roquefeuil G; David M; Boulenger JP; Ritchie K; Mann A
Encephale; 2009 Dec; 35(6):560-9. PubMed ID: 20004287
[TBL] [Abstract][Full Text] [Related]
20. Incorporating multidimensional patient-reported outcomes of symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression to measure treatment impact and recovery in MDD.
Cohen RM; Greenberg JM; IsHak WW
JAMA Psychiatry; 2013 Mar; 70(3):343-50. PubMed ID: 23303512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
